Modified Thoracoabdominal Nerve Plane Block In Laparoscopic Sleeve Gastrectomy

Launched by ISTANBUL MEDIPOL UNIVERSITY HOSPITAL · Jul 17, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating a new method called the Modified Thoracoabdominal Nerve Plane Block (M-TAPA) to help manage pain after a specific type of weight loss surgery called Laparoscopic Sleeve Gastrectomy (LSG). The idea is that by using ultrasound to guide the injection of a local anesthetic into a targeted area of the abdomen, patients may experience less pain and need fewer opioid medications during the first day after their surgery. This is important because managing pain effectively can lead to a better recovery experience.

To participate in this trial, individuals should be between 18 to 75 years old and scheduled for LSG surgery under general anesthesia. However, certain patients are not eligible, including those with bleeding disorders, those taking blood-thinning medications, or those with specific health conditions like liver or kidney disease. Participants can expect to receive the M-TAPA block during their surgery and will be monitored for pain levels and medication use afterward. This study could provide valuable information on improving pain management for patients undergoing weight loss surgery.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria: American Society of Anesthesiologists (ASA) classification II- III Patients Scheduled for LSG under general anesthesia
• • -
• • Exclusion Criteria: Patients
• • with a history of bleeding diathesis,
• • receiving anticoagulant treatment,
• • with allergies or sensitivity to drugs used,
• • with an infection on the puncture site
• • with a history of alcohol or drug addiction,
• • with congestive heart failure
• • with liver or kidney disease
• • who do not accept the procedure or participate in the study